UK markets close in 1 hour 16 minutes

Amgen Inc. (0R0T.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
243.76-3.37 (-1.36%)
As of 07:01PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 317.80%
S&P500 52-week change 322.64%
52-week high 3296.58
52-week low 3211.96
50-day moving average 3254.46
200-day moving average 3243.65

Share statistics

Avg vol (3-month) 324.95k
Avg vol (10-day) 35.02k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8534.35M
% held by insiders 10.25%
% held by institutions 180.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 38.52
Trailing annual dividend yield 33.45%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 23.83%
Operating margin (ttm)8.15%

Management effectiveness

Return on assets (ttm)6.29%
Return on equity (ttm)135.79%

Income statement

Revenue (ttm)28.19B
Revenue per share (ttm)52.69
Quarterly revenue growth (yoy)19.80%
Gross profit (ttm)N/A
EBITDA 12.23B
Net income avi to common (ttm)6.72B
Diluted EPS (ttm)10.12
Quarterly earnings growth (yoy)-52.50%

Balance sheet

Total cash (mrq)10.94B
Total cash per share (mrq)20.42
Total debt (mrq)65.42B
Total debt/equity (mrq)1,049.79%
Current ratio (mrq)1.65
Book value per share (mrq)11.64

Cash flow statement

Operating cash flow (ttm)8.47B
Levered free cash flow (ttm)3.12B